Amisulpride treatment leads to elevated prolactin levels
Clinical literature consistently demonstrates that treatment with the atypical antipsychotic amisulpride leads to elevated serum prolactin levels (hyperprolactinemia) due to its dopamine receptor blockade.
Multiple retrieved papers (0, 3, 9) explicitly identify amisulpride as an antipsychotic that causes significant prolactin elevation. There is no contradictory evidence in the retrieved set regarding this well-documented adverse effect.
Moniem I, Kafetzopoulos V. Sex differences in schizophrenia: symptomatology, treatment efficacy and adverse effects.. 2025. https://doi.org/10.3389/fpsyt.2025.1594334
Paper 0 lists amisulpride among antipsychotics that frequently induce hyperprolactinemia.
See more details
Yao K, Yang L, Zhang Q, Li C, Tian H, Zhuo C. Aripiprazole alleviates the high prolactin levels induced by amisulpride via distinct molecular mechanisms: a network pharmacology and molecular docking study.. 2025. https://doi.org/10.1186/s12888-025-06818-z
Paper 3 specifically investigates mechanisms of amisulpride-induced prolactin elevation.
Hynes-Ryan C, Keating D, Carolan A, Brand B, Dazzan P, Gaughran F, Hahn M, Halstead S, Harrington SM, Hartnett Y, Kelleher I, Lyne J, McNicholas F, O'Connor K, Perry B, Sadowska E, O'Donoghue B, Sommer IE. Clinical Practice Guideline on the Choice of First Antipsychotic Medicine for Females Experiencing a First-Episode of Psychosis.. 2026. https://doi.org/10.1093/schbul/sbag023
Paper 9 classifies amisulpride among medications carrying a higher risk of prolactin elevation.
The paper trail · every fact has a biography
Challenge the receipt
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
Terms · Privacy · How verdicts work · Dispute this receipt